These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23478959)

  • 1. Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.
    García-de-la-Mària C; Pericas JM; Del Río A; Castañeda X; Vila-Farrés X; Armero Y; Espinal PA; Cervera C; Soy D; Falces C; Ninot S; Almela M; Mestres CA; Gatell JM; Vila J; Moreno A; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2013 May; 57(5):2319-25. PubMed ID: 23478959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Pericàs JM; Nathavitharana R; Garcia-de-la-Mària C; Falces C; Ambrosioni J; Almela M; García-González J; Quintana E; Marco F; Moreno A; Bayer AS; Miró JM; Karchmer AW;
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Garcia-de-la-Maria C; Xiong YQ; Pericas JM; Armero Y; Moreno A; Mishra NN; Rybak MJ; Tran TT; Arias CA; Sullam PM; Bayer AS; Miro JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis
    Kebriaei R; Rice SA; Stamper KC; Seepersaud R; Garcia-de-la-Maria C; Mishra NN; Miro JM; Arias CA; Tran TT; Sullam PM; Bayer AS; Rybak MJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
    Yim J; Smith JR; Singh NB; Rice S; Stamper K; Garcia de la Maria C; Bayer AS; Mishra NN; Miró JM; Tran TT; Arias CA; Sullam P; Rybak MJ
    J Antimicrob Chemother; 2017 Aug; 72(8):2290-2296. PubMed ID: 28475731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis
    Mishra NN; Abdelhady W; Elsayed AM; Lapitan C; Proctor RA; Rybak MJ; Miro JM; Bayer AS
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0147222. PubMed ID: 36877026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of High-Level Daptomycin Resistance in
    Cañas MA; Téllez A; García de la Mària C; Dahl A; García-González J; Hernández-Meneses M; Almela M; Ambrosioni J; Falces C; Quintana E; Vidal B; Perissinotti A; Tolosana JM; Sandoval E; Pericàs JM; Moreno A; Miró JM;
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0252220. PubMed ID: 34252304
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
    Zapata B; Alvarez DN; Farah S; Garcia-de-la-Maria C; Miro JM; Sakoulas G; Bayer AS; Mishra NN
    Curr Microbiol; 2018 Aug; 75(8):1062-1067. PubMed ID: 29651552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.
    Akins RL; Katz BD; Monahan C; Alexander D
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2102-12. PubMed ID: 25624330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
    Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronounced heterogeneity observed in high-level daptomycin-resistant viridans group streptococci.
    Akins RL; Barber KE; Palmer KL
    J Glob Antimicrob Resist; 2016 Dec; 7():159-166. PubMed ID: 27835845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Tsuji BT; Rybak MJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2735-45. PubMed ID: 15980344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic modulation of the plasminogen binding ability of viridans group streptococci.
    Teles C; Smith A; Lang S
    Antimicrob Agents Chemother; 2012 Jan; 56(1):458-63. PubMed ID: 22037854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis.
    Hsu RB; Lin FY
    Cardiology; 2006; 105(4):234-9. PubMed ID: 16534200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria.
    Adams HM; Joyce LR; Guan Z; Akins RL; Palmer KL
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.
    Gavaldà J; Pahissa A; Almirante B; Laguarda M; Crespo E; Pou L; Fernández F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2098-103. PubMed ID: 8540723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in
    Tran TT; Mishra NN; Seepersaud R; Diaz L; Rios R; Dinh AQ; Garcia-de-la-Maria C; Rybak MJ; Miro JM; Shelburne SA; Sullam PM; Bayer AS; Arias CA
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with vancomycin of experimental endocarditis caused by Streptococcus sanguis II resistant to penicillin].
    Martínez F; Martín Luengo F; Valdés M
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):255-9. PubMed ID: 8324022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.
    Streit JM; Steenbergen JN; Thorne GM; Alder J; Jones RN
    J Antimicrob Chemother; 2005 Apr; 55(4):574-8. PubMed ID: 15722390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Rose WE; Leonard SN; Rybak MJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3061-7. PubMed ID: 18591272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.